February 28, 2023 12:30 PM ESTUpdated March 2, 03:34 PM
Pharma
Marketing

Mar­ket­ingRx roundup: Ab­b­Vie joins Tik­Tok with friend­ly ex­pert chats; Pfiz­er shops $2.8B mar­ket­ing ac­count

Beth Snyder Bulik

Senior Editor

Ab­b­Vie joined the hip­ster crowd on Tik­Tok with a new cor­po­rate brand­ed US han­dle. Launched a few weeks ago, the ac­count …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times